Systematic (IUPAC) name | |
---|---|
5-phenyl-7-(trifluoromethyl)-1,3-dihydro-1,4-benzodiazepin-2-one
|
|
Identifiers | |
CAS Registry Number | 2285-16-7 |
ATC code | None |
PubChem | CID: 16795 |
Chemical data | |
Formula | C16H11F3N2O |
Molecular mass | 304.267 |
|
|
(what is this?) (verify) |
Ro5-2904[1] (Triflunordazepam) is a drug which is a benzodiazepine derivative with high GABAA receptor affinity, and has anticonvulsant effects.[2][3]
See also
References
- ^ DE Patent 1136709
- ^ Archives Internationales de Pharmacodynamie et de Therapie. (1965). Vol 154, p 131.
- ^ So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry 39 (26): 5246–56. doi:10.1021/jm960536o. PMID 8978853.
|